Randomized pilot clinical trial to demonstrate superiority of bisphosphonate-magnesium
combination over bisphosphonates alone in postmenopausal osteoporosis in slowing bone
remodeling as assessed by C-terminal telopeptide of bone collagen type 1 (CTX) dosage.